These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 34671530)
1. Management of COVID-19-Related Severe Acute Respiratory Distress Syndrome in a Patient With Active Human Immunodeficiency Virus Infection. Panda R; Singh P; Saigal S; Karna ST Cureus; 2021 Sep; 13(9):e18045. PubMed ID: 34671530 [TBL] [Abstract][Full Text] [Related]
2. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy. Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317 [TBL] [Abstract][Full Text] [Related]
3. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
4. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial. Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739 [TBL] [Abstract][Full Text] [Related]
5. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial. Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611 [TBL] [Abstract][Full Text] [Related]
6. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic. Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359 [TBL] [Abstract][Full Text] [Related]
7. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial. Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777 [TBL] [Abstract][Full Text] [Related]
8. Lung ultrasound-guided treatment for acute respiratory distress syndrome in a critically ill patient with severe COVID-19: a case report. Fan H; Tong H; Chen K Ann Palliat Med; 2022 Dec; 11(12):3794-3803. PubMed ID: 36636003 [TBL] [Abstract][Full Text] [Related]
9. Increased physiological dead space in mechanically ventilated COVID-19 patients recovering from severe acute respiratory distress syndrome: a case report. Xia J; Feng Y; Li M; Yu X; Zhang Y; Duan J; Zhan Q BMC Infect Dis; 2020 Aug; 20(1):637. PubMed ID: 32854630 [TBL] [Abstract][Full Text] [Related]
10. COVID-19-associated acute respiratory distress syndrome versus classical acute respiratory distress syndrome (a narrative review). Krynytska I; Marushchak M; Birchenko I; Dovgalyuk A; Tokarskyy O Iran J Microbiol; 2021 Dec; 13(6):737-747. PubMed ID: 35222850 [TBL] [Abstract][Full Text] [Related]
11. Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review. Montenegro F; Unigarro L; Paredes G; Moya T; Romero A; Torres L; López JC; González FEJ; Del Pozo G; López-Cortés A; Diaz AM; Vasconez E; Cevallos-Robalino D; Lister A; Ortiz-Prado E Expert Rev Respir Med; 2021 Feb; 15(2):183-195. PubMed ID: 32902367 [TBL] [Abstract][Full Text] [Related]
12. Flow controlled ventilation in Acute Respiratory Distress Syndrome associated with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Roehrig S; Ait Hssain A; Shallik NAH; Elsaid IMA; Mustafa SF; Smain OAM; Molokhia AA; Lance MD Trials; 2020 Sep; 21(1):781. PubMed ID: 32917259 [TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
15. Case Fatality of Hospitalized Patients with COVID-19 Infection Suffering from Acute Respiratory Distress Syndrome in Germany. Sagoschen I; Keller K; Wild J; Münzel T; Hobohm L Viruses; 2022 Nov; 14(11):. PubMed ID: 36423124 [No Abstract] [Full Text] [Related]
16. Acute Respiratory Distress Syndrome and Time to Weaning Off the Invasive Mechanical Ventilator among Patients with COVID-19 Pneumonia. Bordon J; Akca O; Furmanek S; Cavallazzi RS; Suliman S; Aboelnasr A; Sinanova B; Ramirez JA J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34208922 [TBL] [Abstract][Full Text] [Related]
17. A Case of the Use of Extracorporeal Carbon Dioxide Removal in a Patient With COVID-19 Acute Respiratory Distress Syndrome. Firzli TR; Sathappan S; Siddiqui F Cureus; 2022 May; 14(5):e24645. PubMed ID: 35663663 [TBL] [Abstract][Full Text] [Related]
18. COVID-19 ARDS: a review of imaging features and overview of mechanical ventilation and its complications. Gosangi B; Rubinowitz AN; Irugu D; Gange C; Bader A; Cortopassi I Emerg Radiol; 2022 Feb; 29(1):23-34. PubMed ID: 34698956 [TBL] [Abstract][Full Text] [Related]
19. Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection. Cinesi Gómez C; Peñuelas Rodríguez Ó; Luján Torné M; Egea Santaolalla C; Masa Jiménez JF; García Fernández J; Carratalá Perales JM; Heili-Frades SB; Ferrer Monreal M; de Andrés Nilsson JM; Lista Arias E; Sánchez Rocamora JL; Garrote JI; Zamorano Serrano MJ; González Martínez M; Farrero Muñoz E; Mediano San Andrés O; Rialp Cervera G; Mas Serra A; Hernández Martínez G; de Haro López C; Roca Gas O; Ferrer Roca R; Romero Berrocal A; Ferrando Ortola C Med Intensiva (Engl Ed); 2020 Oct; 44(7):429-438. PubMed ID: 32312600 [TBL] [Abstract][Full Text] [Related]
20. Effect of Intubation Timing on the Outcome of Patients With Severe Respiratory Distress Secondary to COVID-19 Pneumonia. Fayed M; Patel N; Yeldo N; Nowak K; Penning DH; Vasconcelos Torres F; Natour AK; Chhina A Cureus; 2021 Nov; 13(11):e19620. PubMed ID: 34804753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]